Senese Silvia, Zaragoza Katrin, Minardi Simone, Muradore Ivan, Ronzoni Simona, Passafaro Alfonso, Bernard Loris, Draetta Giulio F, Alcalay Myriam, Seiser Christian, Chiocca Susanna
European Institute of Oncology, Department of Experimental Oncology, Via Ripamonti 435, 20141 Milan, Italy.
Mol Cell Biol. 2007 Jul;27(13):4784-95. doi: 10.1128/MCB.00494-07. Epub 2007 Apr 30.
Posttranslational modifications of core histones are central to the regulation of gene expression. Histone deacetylases (HDACs) repress transcription by deacetylating histones, and class I HDACs have a crucial role in mouse, Xenopus laevis, zebra fish, and Caenorhabditis elegans development. The role of individual class I HDACs in tumor cell proliferation was investigated using RNA interference-mediated protein knockdown. We show here that in the absence of HDAC1 cells can arrest either at the G(1) phase of the cell cycle or at the G(2)/M transition, resulting in the loss of mitotic cells, cell growth inhibition, and an increase in the percentage of apoptotic cells. On the contrary, HDAC2 knockdown showed no effect on cell proliferation unless we concurrently knocked down HDAC1. Using gene expression profiling analysis, we found that inactivation of HDAC1 affected the transcription of specific target genes involved in proliferation and apoptosis. Furthermore, HDAC2 downregulation did not cause significant changes compared to control cells, while inactivation of HDAC1, HDAC1 plus HDAC2, or HDAC3 resulted in more distinct clusters. Loss of these HDACs might impair cell cycle progression by affecting not only the transcription of specific target genes but also other biological processes. Our data support the idea that a drug targeting specific HDACs could be highly beneficial in the treatment of cancer.
核心组蛋白的翻译后修饰是基因表达调控的关键。组蛋白去乙酰化酶(HDACs)通过使组蛋白去乙酰化来抑制转录,而I类HDACs在小鼠、非洲爪蟾、斑马鱼和秀丽隐杆线虫的发育中起关键作用。使用RNA干扰介导的蛋白敲低技术研究了单个I类HDACs在肿瘤细胞增殖中的作用。我们在此表明,在缺乏HDAC1的情况下,细胞可停滞于细胞周期的G(1)期或G(2)/M转换期,导致有丝分裂细胞丢失、细胞生长抑制以及凋亡细胞百分比增加。相反,HDAC2敲低对细胞增殖无影响,除非我们同时敲低HDAC1。通过基因表达谱分析,我们发现HDAC1的失活影响了参与增殖和凋亡的特定靶基因的转录。此外,与对照细胞相比,HDAC2的下调未引起显著变化,而HDAC1、HDAC1加HDAC2或HDAC3的失活导致了更明显的聚类。这些HDACs的缺失可能不仅通过影响特定靶基因的转录,还通过影响其他生物学过程来损害细胞周期进程。我们的数据支持这样一种观点,即靶向特定HDACs的药物在癌症治疗中可能非常有益。